Democrats and Republicans agree: we need to address the lack of competition in the pharmaceutical industry and rising cost of prescription drugs. Advancing these bills today reflects this Committees continued focus on moving meaningful bipartisan legislation to the Senate floor. https://t.co/ahQmR0kNVs